Lorazepam vs Nivolumab
Lorazepam vs Nivolumab: Overview
This comparison examines the pharmacological differences between Lorazepam and Nivolumab.
Mechanism of Action
Lorazepam: Intermediate-acting benzodiazepine enhancing GABA-A receptor chloride conductance.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Lorazepam β 10-20 hours; Nivolumab β 27 days.
Chemical Properties
Molecular Formula: Lorazepam β C15H10Cl2N2O2.
Molecular Weight: Lorazepam β 321.1580 g/mol.
Type: Lorazepam β Small molecule; Nivolumab β Antibody.